Portfolio Management Services (PMS)
Compare Schemes

Nuvama Equities eXpansion Target vs Polaris Human Plus Machine Converged Equity Strategy

Nuvama Equities eXpansion Target
Polaris Human Plus Machine Converged Equity Strategy
Add Scheme
Growth of ₹1 Crore
Nuvama Equities eXpansion Target
Polaris Human Plus Machine Converged Equity Strategy
Return for the risk
3 yrs return
5%
10%
15%
20%
Nifty 500 · 12.1%
10%
20%
30%
Volatility • 3 yrs deviation
1 Month
2.94%
9.44%
6 Months
19.15%
2.42%
1 Year
14.85%
1.29%
3 Years
14.64%
—
5 Years
—
—
Since Inception
15.52%
23.68%
Fund Age
3 yrs 3 mo
4 mo
AUM
₹213.16 Cr
₹2.91 Cr
Alpha – 1 Year
10.13%
0.33%
Alpha – 3 Years
2.55%
—
Information Ratio – 3 Years
0.17
—
Volatility – 1 Year
28.62%
—
Volatility – 3 Years
24.62%
—
Beta – 1 Year
1.48
—
Beta – 3 Years
1.33
—
Sharpe Ratio – 1 Year
0.43
—
Sharpe Ratio – 3 Years
0.46
—
Worst Rolling Year
12.87%
—
Value at Worst Rolling Year
₹1.13 Cr
—
Deepest Drawdown
−26.40%
—
Recovery Period
Not yet recovered
—
1-Year Rolling Windows Positive
100.00%
—
Median Rolling Year
15.08%
—
5-Year Rolling Windows Positive
—
—
Market-Cap Mix
—
M 5% · S 92%
Number of Stocks
33
29
Portfolio P/E
—
67.46
Top 5 Holdings
—
Shilpa Medicare Ltd · 11.42%
Cash & Cash Equivalent · 7.83%
Himadri Speciality Chemical Ltd · 7.42%
Sheela Foam Ltd · 6.84%
Rubicon Research Ltd · 6.78%
Top Sectors
—
Healthcare · 31.15%
Capital Goods · 20.12%
Chemicals · 13.97%
Fixed Fee
2.50% / yr
0.50% / yr
Performance Fee / Plan
Fixed Plan
Fixed Plan
Exit Load (Y1 / Y2 / Y3)
2% / 1% / 0%
0% / 0% / 0%
Let's start a
conversation
  • Compare this PMS against 3,000+ others with our research desk
  • Build a long-term portfolio around your goals, not a one-off buy
  • Experts with decades of experience.
Private. Personal. No obligation.
We will only use these details to contact you about this enquiry. No spam.
Start a conversation
Share a few details and an expert will reach out.
We will only use these details to contact you about this enquiry. No spam.